id	domain	url
dhrp-29	doi.org	https://doi.org/10.47488/dhrp.v1is4.29
dhrp-29	dhrproceedings.org	http://dhrproceedings.org
dhrp-29	dhrproceedings.org	http://dhrproceedings.org
dhrp-29	coronavirus.jhu.edu	https://coronavirus.jhu.edu/map.html
dhrp-29	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fdaapproves-first-covid-19-vaccine
dhrp-29	combatcovid.hhs.gov	https://combatcovid.hhs.gov/i-have-covid-19-now/availablecovid-19-treatment-options
dhrp-29	www.merck.com	https://www.merck.com/news/merck-and-ridgebacksinvestigational-oral-antiviral-molnupiravir-reduced-the-risk-ofhospitalization-or-death-by-approximately-50-percentcompared-to-placebo-for-patients-with-mild-or-moderat
dhrp-29	orcid.org	https://orcid.org/0000-0001-50279992
dhrp-29	orcid.org	https://orcid.org/0000-00034146-3282
dhrp-29	coronavirus.jhu.edu	https://coronavirus.jhu.edu/map.html
dhrp-29	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
dhrp-29	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
dhrp-29	combatcovid.hhs.gov	https://combatcovid.hhs.gov/i-have-covid-19-now/available-covid-19-treatment-options
dhrp-29	combatcovid.hhs.gov	https://combatcovid.hhs.gov/i-have-covid-19-now/available-covid-19-treatment-options
dhrp-29	www.merck.com	https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat
dhrp-29	www.merck.com	https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat
dhrp-29	www.merck.com	https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat
dhrp-29	www.merck.com	https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat
dhrp-29	orcid.org	https://orcid.org/0000-0001-5027-9992
dhrp-29	orcid.org	https://orcid.org/0000-0001-5027-9992
dhrp-29	orcid.org	https://orcid.org/0000-0003-4146-3282
dhrp-29	orcid.org	https://orcid.org/0000-0003-4146-3282